In Vitro and in Vivo Studies on Mucoadhesive Microspheres of Amoxicillin
Overview
Affiliations
Amoxicillin mucoadhesive microspheres (Amo-ad-ms) were prepared using ethylcellulose (Ec) as matrix and carbopol 934P as mucoadhesive polymer for the potential use of treating gastric and duodenal ulcers, which were associated with Helicobacter pylori. The morphological characteristics of the mucoadhesive microspheres were studied under scanning electron microscope. In vitro release test showed that amoxicillin released faster in pH 1.0 hydrochloric acid (HCl) than in pH 7.8 phosphate buffer. Yet, it would be degraded to some extent in a pH 1.0 HCl medium at 37 degrees C, which indicated that amoxicillin was not stable in an acidic surrounding. It was also found that amoxicillin entrapped within the microspheres could keep stable. In vitro and in vivo mucoadhesive tests showed that Amo-ad-ms adhered more strongly to gastric mucous layer than nonadhesive amoxicillin microspheres (Amo-Ec-ms) did and could retain in gastrointestinal tract for an extended period of time. Amo-ad-ms and amoxicillin powder were orally administered to rats. The amoxicillin concentration in gastric tissue was higher in the Amo-ad-ms group. In vivo H. pylori clearance tests were also carried out by administering, respectively, Amo-ad-ms or amoxicillin powder, to H. pylori infectious BALB/c mice under fed conditions at single or multiple dose(s) in oral administration. The results showed that Amo-ad-ms had a better clearance effect than amoxicillin powder did. In conclusion, the prolonged gastrointestinal residence time and enhanced amoxicillin stability resulting from the mucoadhesive microspheres of amoxicillin might make contribution to H. pylori clearance.
Characterization of an In Vitro/Ex Vivo Mucoadhesiveness Measurement Method of PVA Films.
Muller L, Rosenbaum C, Krause J, Weitschies W Polymers (Basel). 2022; 14(23).
PMID: 36501540 PMC: 9741245. DOI: 10.3390/polym14235146.
Hadke J, Khan S Turk J Pharm Sci. 2021; 18(4):388-397.
PMID: 34496478 PMC: 8430400. DOI: 10.4274/tjps.galenos.2020.33341.
Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery.
Das S, Kaur S, Rai V Drug Deliv Transl Res. 2021; 11(5):1849-1877.
PMID: 33403646 DOI: 10.1007/s13346-020-00875-5.
In Vitro and In Vivo Test Methods for the Evaluation of Gastroretentive Dosage Forms.
Schneider F, Koziolek M, Weitschies W Pharmaceutics. 2019; 11(8).
PMID: 31426417 PMC: 6723944. DOI: 10.3390/pharmaceutics11080416.
Raghuvanshi S, Pathak K Int J Pharm Investig. 2017; 6(4):181-193.
PMID: 28123987 PMC: 5204249. DOI: 10.4103/2230-973X.195923.